For instance, high levels of glucose-6-phosphate dehydrogenase (G6PD) and polo-like kinase 1 (PLK1) expression have been related to chemotherapy resistance in CRC [53, 54]. The gene discussed is PLK1; the disease is colorectal carcinoma.